Inequality and Human Genetics
By Richard Hayes,
The New York Times
| 09. 16. 2008
[Letter to the editor]
David Frum correctly acknowledges that income inequality in the United States has been growing steadily and that the use of genetic technology by the affluent to enhance the "intelligence, health, beauty and strength" of their offspring would exacerbate this trend. But his suggestion that this challenge could be addressed by somehow ensuring that all have access to such technology is woefully misguided. The advent of these technologies would spark a techno-eugenic rat race impossible to constrain absent some system of authoritarian, allocative control. It would fundamentally change the way people regard their children and one another and undermine the integrity of the common human nature that sustains all human values, beliefs and institutions. The genetic modification of our children is a practice that conservatives and liberals alike should be able to agree poses far more risks than benefits, and should be taken off the table as an option.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif.
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...